Ticker: KALV

Company: KalVista Pharmaceuticals, Inc.

Person: Benjamin L Palleiko, director, officer

Transaction date: May 11, 2026

Reporting date: May 13, 2026

Average share price: -23.36245918904687

Sold 3798.0 shares for 88730.62